Back
Aadi Bioscience Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
60
AADI
Aadi Bioscience
Last Price:
1.83
Seasonality Move:
16.08%
Sell
20
NBY
NovaBay Pharmaceuticals
Last Price:
0.09
Seasonality Move:
-7.96%
Buy
60
Aadi Bioscience (AADI)
is a Buy
Is Aadi Bioscience a Buy, Sell or Hold?
- The current Aadi Bioscience [AADI] share price is $2.13. The Score for AADI is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- AADI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.09. The Score for NBY is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
AADI Stock Price Chart
What is Aadi Bioscience's stock price today?
-
The Aadi Bioscience share price today is $2.13
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AADI is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.09
The current trend is relatively stagnant and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
AADI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 57.88 | Buy |
| Chaikin Money Flow: | 115100 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.81 - 2.09) | Buy |
| Bollinger Bands (100): | (1.52 - 2.54) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 43.3 | Sell |
| Chaikin Money Flow: | 1873744 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.08 - 0.1) | Sell |
| Bollinger Bands (100): | (0.1 - 0.2) | Sell |
AADI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.97 | Buy |
| 20-day SMA: | 1.9 | Buy |
| 50-day SMA: | 2.05 | Buy |
| 200-day SMA: | 3.58 | Sell |
| 8-day EMA: | 2 | Buy |
| 20-day EMA: | 1.96 | Buy |
| 50-day EMA: | 2.04 | Buy |
| 200-day EMA: | 3.74 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.09 | Sell |
| 20-day SMA: | 0.08 | Buy |
| 50-day SMA: | 0.11 | Sell |
| 200-day SMA: | 0.31 | Sell |
| 8-day EMA: | 0.09 | Sell |
| 20-day EMA: | 0.09 | Sell |
| 50-day EMA: | 0.11 | Sell |
| 200-day EMA: | 0.54 | Sell |
Aadi Bioscience Earnings Growth & AADI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.18 per share, a decrease this year of $0.02 per share, and a decrease next year of $0.60 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.04 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.
Aadi Bioscience Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||